Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Share-based Compensation (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Share-based Compensation for 4 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 125.64% to $3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.5 million through Dec 2025, up 65.46% year-over-year, with the annual reading at $12.5 million for FY2025, 97.12% up from the prior year.
  • Share-based Compensation for Q4 2025 was $3.7 million at LENZ Therapeutics, up from $3.5 million in the prior quarter.
  • The five-year high for Share-based Compensation was $3.7 million in Q4 2025, with the low at $142000.0 in Q1 2023.
  • Average Share-based Compensation over 4 years is $2.6 million, with a median of $2.8 million recorded in 2023.
  • The sharpest move saw Share-based Compensation tumbled 95.75% in 2023, then skyrocketed 566.9% in 2024.
  • Over 4 years, Share-based Compensation stood at $3.6 million in 2022, then plummeted by 40.34% to $2.2 million in 2023, then decreased by 24.57% to $1.6 million in 2024, then skyrocketed by 125.64% to $3.7 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $3.7 million, $3.5 million, and $2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.